Blossom Pulse Archive

What happened in psychedelic research in 1994

2 events from 1994, dated by when they happened rather than when we logged them. Papers as they published, trials starting and finishing, programme milestones, and the news coverage around them, grouped by week.

Browse by year

Week of 31 January 1994

  • This randomised, double-blind, placebo-controlled study (n=12) investigated the subjective effects of graded doses of DMT in hallucinogen-experienced users. Effects began almost immediately after DMT administration, peaking at 90 to 120 seconds, and were almost completely resolved by 30 minutes. Hallucinogenic effects were seen after 14 and 21 mg/70kg of DMT, while lower doses, 70 and 35 mg/70kg, were primarily affective and somaesthetic (body + sensory perception).

    LSDDMTPsilocybinAnxiety Disorders

    View paper

  • This study (1994) was one of the first sanctioned studies using psychedelics following their classification as Schedule I substances. Participants received intravenous doses of DMT at 0.05,0.1,0.2, and 0.4 mg/kg. Neuroendocrine, autonomic, and cardiovascular effects were assessed. It was found that DMT can be safely administered to experienced hallucinogen users.

    DMT

    View paper

Showing 2 of 2 in 1994